Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease.
Popat, R. A.; Van Den Eeden, S. K.; Tanner, C. M.; Kamel, F.; Umbach, D. M.; Marder, K.; Mayeux, R.; Ritz, B.; Ross, G. W.; Petrovitch, H.; Topol, B.; McGuire, V.; Costello, S.; Manthripragada, A. D.; Southwick, A.; Myers, R. M.; Nelson, L. M.; European Journal of Neurology, 2011, vol. 18, issue 5, p 756, ISSN 13515101. ISBN 14681331.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef